1. Home
  2. MCI vs LAB Comparison

MCI vs LAB Comparison

Compare MCI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Corporate Investors

MCI

Barings Corporate Investors

HOLD

Current Price

$20.00

Market Cap

408.6M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$1.57

Market Cap

488.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCI
LAB
Founded
1971
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
408.6M
488.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
MCI
LAB
Price
$20.00
$1.57
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$1.35
AVG Volume (30 Days)
40.4K
1.8M
Earning Date
01-01-0001
02-25-2026
Dividend Yield
8.46%
N/A
EPS Growth
N/A
N/A
EPS
1.82
N/A
Revenue
N/A
$169,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.88
N/A
Revenue Growth
N/A
79.77
52 Week Low
$12.96
$0.92
52 Week High
$19.24
$2.05

Technical Indicators

Market Signals
Indicator
MCI
LAB
Relative Strength Index (RSI) 56.94 57.59
Support Level $18.65 $1.54
Resistance Level $19.45 $1.66
Average True Range (ATR) 0.54 0.08
MACD 0.15 0.02
Stochastic Oscillator 86.30 76.74

Price Performance

Historical Comparison
MCI
LAB

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: